Analyst Pin-board: IMP – 2020’s bidding result YTD and a quick review on other competitors in tier 1 & 2 drug bid
For IMP, business prospects come mainly from the ETC channel (hospitals), considering that the OTC channel (pharmacies) is stacked with competition and is not a huge market either (only 25% of total drug sales in Vietnam). On the other hand, ETC channel offers a lot of potential for EU-GMP standard manufacturers to replace foreign medicines in the Tier 1 and 2 bid. Policy wise, Circular 15/2019 was really a big catalyst for the like of IMP.
Viet Dragon Securities belongs to top 20 biggest securities companies in terms of chartered capital in Vietnam. With a qualified, dedicated and professional team, a widespread network, advanced technology, diversified products and services, and good relationship with local and foreign institutions, we provide a wide range of services and products to our clients both individuals and institutions, both local and foreign. We commit to provide our clients with promising investment opportunities and a comprehensive and professional financial investment services.
RongViet Research reports are diversified and abundant, along with in-depth analysis and performed by experienced, highly-qualified and knowledgeable teams. With the objectives of transparency, accurate and timely manner, RongViet believes that our products would always be important sources of information for customers/investors’ investment decisions.”
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.